Placulumab

Last updated
Placulumab
Monoclonal antibody
Type ?
Source Human
Target TNF
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
Chemical and physical data
Formula C3404H5262N902O1036S22
Molar mass 76104.14 g·mol−1

Placulumab is a human monoclonal antibody designed for the treatment of inflammatory diseases. [1]

This drug was developed by Teva Pharmaceutical Industries, Inc. As of 2012, development of placulumab has been discontinued.

References

  1. Statement On A Nonproprietary Name Adopted By The USAN Council - Placulumab, American Medical Association .